EU pharma wholesalers warn new falsified medicines directive could affect delivery processes
This article was originally published in SRA
Executive Summary
The European Association of Pharmaceutical Full-line Wholesalers ( GIRP) has warned that some aspects of the new falsified medicines directive could have an adverse impact on the current pace and speed of delivery of medicines to Europe's pharmacies1.